Skip to main content
. Author manuscript; available in PMC: 2021 Apr 15.
Published in final edited form as: Clin Cancer Res. 2019 Dec 18;26(8):1924–1931. doi: 10.1158/1078-0432.CCR-19-0306

Figure 1. cfDNA Alterations by Site of Malignancy.

Figure 1.

A. Number of alterations vs primary malignancy site. B. Number of nonsynonymous vs primary malignancy site. C. Maximum variant allele frequency (VAF) vs site of primary malignancy